Novel antifungal agents in clinical trials [version 2; peer review: 2 approved]

Invasive fungal diseases due to resistant yeasts and molds are an important and increasing public health threat, likely due to a growing population of immunosuppressed hosts, increases in antifungal resistance, and improvements in laboratory diagnostics. The significant morbidity and mortality asso...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	F1000 research Ročník 10; s. 507
Hlavní autoři:	Jacobs, Samantha E, Zagaliotis, Panagiotis, Walsh, Thomas J
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England Faculty of 1000 Ltd 2022 F1000 Research Limited F1000 Research Ltd
Témata:	Amphotericin B Antifungal Agents Antifungal Agents - pharmacology Antifungal Agents - therapeutic use Biosynthesis Clinical trials Drug dosages Drug interactions Drug Resistance, Fungal eng Enzymes Fungi Immunocompromised Host Meningitis Morbidity Neutropenia novel treatments Pathogens Pharmacodynamics pharmacokinetic and pharmacodynamic Pharmacokinetics Proteins Public health Review Antifungal Agents clinical trials pharmacokinetic and pharmacodynamic novel treatments
ISSN:	2046-1402, 2046-1402
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!